Research Article

Prevalence and Antimicrobial Susceptibility of Streptococcus pneumoniae Isolated from Clinical Samples in the Past 8 Years in Korea

Table 6

Antimicrobial susceptibility (%) pattern of Streptococcus pneumoniae isolated from noninvasive specimens.

Antimicrobial agentsNo. of isolatesResistantIntermediateSusceptible
% of isolatesMIC breakpoints (μg/mL)% of isolatesMIC breakpoints (μg/mL)% of isolatesMIC breakpoints (μg/mL)

Clindamycin64467.2≥10.90.531.9≤0.25
Cefotaxime65113.7≥414.1272.2≤1
Ceftriaxone65014.8≥47.2278.0≤1
Erythromycin63679.7≥10.50.519.8≤0.25
Levofloxacin6519.1≥80.9490.0≤2
Penicillin G6557.9≥811.0481.1≤2
Cotrimoxazole65540.8≥4/7611.41/19~2/3847.8≤0.5/9.5
Tetracycline65072.3≥40.9226.8≤1
Vancomycin65500100.0≤1